NOVALIQ ANNOUNCES POSITIVE TOPLINE RESULTS FOR SECOND PHASE 3 ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
HEIDELBERG, Germany and CAMBRIDGE, MA Dec. 21, 2021 /PRNewswire-AsiaNet/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol(R) water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investiga...
Authors: LATEST ASIANET NEWS RELEASES